Calithera Biosciences
Stock Forecast, Prediction & Price Target
Calithera Biosciences Financial Estimates
Calithera Biosciences Revenue Estimates
Calithera Biosciences EBITDA Estimates
Calithera Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $9.75M 0% | $0 -100% | Avg: $247.98M Low: $247.98M High: $247.98M avg. 0% | |||
Net Income
% change YoY
| $-88.52M N/A | $-165.33M -86.77% | $-18.86M 88.58% | Avg: $-10.53M Low: $-10.53M High: $-10.53M avg. 44.16% | |||
EBITDA
% change YoY
| $-88.26M N/A | $-13.68M 84.49% | $-43.76M -219.85% | Avg: $49.59M Low: $49.59M High: $49.59M avg. 213.32% | |||
EPS
% change YoY
| -$25.73 N/A | -$44.77 -73.99% | -$3.78 91.55% | Avg: -$2.11 Low: -$2.11 High: -$2.11 avg. 44.17% | |||
Operating Expenses
% change YoY
| $91.38M N/A | $74.30M -18.68% | $42.07M -43.37% | Avg: $284.60M Low: $284.60M High: $284.60M avg. 576.43% | |||
FAQ
What is Calithera Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 44.16% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -10.53M, average is -10.53M and high is -10.53M.
What is Calithera Biosciences stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is $247.98M, average is $247.98M and high is $247.98M.
What is Calithera Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 44.17% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$2.11, average is -$2.11 and high is $-2.11.
What is the best performing analyst?
In the last twelve months analysts have been covering Calithera Biosciences stock. The most successful analyst is Aydin Huseynov whose win rate is 100%. He has correctly predicted 1/1 price targets.